PATENT CLAIM ANALYSIS

Application Number: 16028858
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "033000"]

Abstract:
The present disclosure relates to treatment of a pulmonary disease. The methods and kits provided herein facilitate relieving the symptoms resulting from the pulmonary disease (e.g., asthma, chronic obstructive pulmonary disease (COPD), etc.).

Claim (Index 1):
A method for treating a pulmonary disease comprising administering to a subject in need thereof a therapeutically effective amount of an isolated compound of formula (I) or stereoisomer, enantiomer, tautomer or a pharmaceutically acceptable salt thereof: wherein: the A, B, C, D, or E ring is independently fully saturated or partially saturated; R 1  is a carbohydrate residue; the positions of C2, C11, C12, and C19 are each independently substituted with hydrogen or \u2014OH; R 2a  and R 2b  together form \u2014CO 2 \u2014; R 3a  and R 3b  together form CH 2 , or are each independently selected from \u2014CH 3  or \u2014CH 2 \u2014OH.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 95.0
- Lexical Diversity: 1.3871
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15129965', '14366218', '12312749', '12596068', '13471111']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7160755342304401
- 35 USC 102 Novelty (BERT): 0.6613381888757953
- Combined Prediction Score: 0.7106017996949756
- Mean Citation Score: 298.657284
- Max Citation Score: 705.1274400000003
- Similarity Product: 605.094146866565

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test